View all cases
- Case details
- Status—ActionProcedural applicationCategoryCase management orders
- Parties
- Respondents
- Dexcom International LimitedOperating co.
- Dexcom Inc.Operating co.
Representatives- Tjibbe Douma-Bird & Bird LLP
- Division
- The Hague LD
- Judges
- Technology
- InstrumentsMedical technology
- Language
- —
- First decided
- Sep 17, 2024
- EPO Opposition
- Dexcom, Inc.Withdrawn2024-03-14
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| The Hague LD | Locked |
| Judge Edger Brinkman | Locked |
At the UPC: Abbott Group (67 cases)·Dexcom Group (39 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
CC 20188/2024·CC 13509/2024·UPC CFI 425/2023·UPC CFI 424/2023·UPC APP 36267/2024 and 4 more
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2024
Decisions
- 2024-09-17Amend DocumentPublic
Summary: The Hague Local Division issued a procedural order on Dexcom's request to amend its counterclaim for revocation against Abbott Diabetes Care concerning EP4070727, to add a declaration of non-infringement for the Dexcom G7-System used with a G7-Receiver following Abbott's partial withdrawal of its infringement claim concerning that product.
Show the legal issues (3)
- Amendment of counterclaim for revocation (R.263 RoP)
- Declaration of non-infringement following partial withdrawal of infringement claim
- Legitimate interest in amendment
Documents
- 4329DDC9751528CA44698E2EEFECDA8F_en.pdf2024-09-17EN